Quick Answer
Black Garlic Lipid Markers Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Background Aged black garlic (ABG) is rich in organosulfur compounds such as S-allyl-cysteine (SAC) and may influence lipid metabolism, although evidence from controlled trials remains limited.
Key Takeaways
- 01Background Aged black garlic (ABG) is rich in organosulfur compounds such as S-allyl-cysteine (SAC) and may influence lipid metabolism, although evidence from controlled trials remains limited. [Serrano JCE (2026)]
- 02In secondary exploratory analyses of NMR-derived lipoprotein subclasses, nominally significant differences were observed: ABG was associated with a reduction in the total number of particles and HDL particles. [Serrano JCE (2026)]
- 03Conclusion Low-dose ABG supplementation did not significantly modify conventional lipid markers in Grade I hypertensive individuals. [Serrano JCE (2026)]
- 04The aim of this study was to evaluate the impact of a low-dose SAC-optimized ABG on blood lipid profiles in Grade I hypertensive individuals. [Serrano JCE (2026)]
The current Migaku evidence database contains 1 reusable source document for Black Garlic Lipid Markers Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Background Aged black garlic (ABG) is rich in organosulfur compounds such as S-allyl-cysteine (SAC) and may influence lipid metabolism, although evidence from controlled trials remains limited. [Serrano JCE (2026); evidence level 2]
- In secondary exploratory analyses of NMR-derived lipoprotein subclasses, nominally significant differences were observed: ABG was associated with a reduction in the total number of particles and HDL particles. [Serrano JCE (2026); evidence level 2]
- Conclusion Low-dose ABG supplementation did not significantly modify conventional lipid markers in Grade I hypertensive individuals. [Serrano JCE (2026); evidence level 2]
- The aim of this study was to evaluate the impact of a low-dose SAC-optimized ABG on blood lipid profiles in Grade I hypertensive individuals. [Serrano JCE (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources